Peroxisome proliferator-activated receptor-γ gene polymorphism in psoriasis and its relation to obesity, metabolic syndrome, and narrowband ultraviolet B response: A case–control study in Egyptian patients

Background: Psoriasis is a common dermatologic disease with multifactorial etiology in which genetic factors play a major role. Peroxisome proliferator-activated receptor (PPAR)-γ is expressed in keratinocytes and is known to affect cell maturation and differentiation in addition to its role in infl...

Full description

Bibliographic Details
Main Authors: Iman Seleit, Ola Ahmed Bakry, Eman Abd El Gayed, Mai Ghanem
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Indian Journal of Dermatology
Subjects:
Online Access:http://www.e-ijd.org/article.asp?issn=0019-5154;year=2019;volume=64;issue=3;spage=192;epage=200;aulast=Seleit
_version_ 1818468672692289536
author Iman Seleit
Ola Ahmed Bakry
Eman Abd El Gayed
Mai Ghanem
author_facet Iman Seleit
Ola Ahmed Bakry
Eman Abd El Gayed
Mai Ghanem
author_sort Iman Seleit
collection DOAJ
description Background: Psoriasis is a common dermatologic disease with multifactorial etiology in which genetic factors play a major role. Peroxisome proliferator-activated receptor (PPAR)-γ is expressed in keratinocytes and is known to affect cell maturation and differentiation in addition to its role in inflammation. Aim: To study the association between PPAR-γ gene polymorphism and psoriasis vulgaris in Egyptian patients to explore if this polymorphism influenced disease risk or clinical presentation. Methods: Forty-five patients with psoriasis vulgaris and 45 age, sex and body mass index matched healthy volunteers who have no present, past or family history of psoriasis as a control group were enrolled. Selected cases included obese and nonobese participants. Detection of PPAR-γ gene polymorphism was done with restriction fragment length polymorphism polymerase chain reaction. Narrow-band ultraviolet B (NBUVB) was given for every case three times/week for 12 weeks. Results: Homopolymorphism, heteropolymorphism, and Ala allele were significantly associated with cases (P = 0.01, P = 0.01, and P = 0.004, respectively) and increased risk of occurrence of psoriasis by 5.25, 3.65, and 3.37 folds, respectively. Heteropolymorphism was significantly associated with nonobese cases compared to obese ones (P = 0.01). Ala allele was significantly associated with obese cases (P = 0.001) and increased risk of occurrence of psoriasis in obese participants by 1.14 folds. Homopolymorphism, heteropolymorphism, and Ala allele were more prevalent among obese cases without metabolic syndrome (MS) than obese cases with MS but without statistical significance. Percentage of decrease of mean Psoriasis Area and Severity Index score before and after 3 months of treatment with NBUVB was higher in cases with heteropolymorphism with no significant difference between homo- and heteropolymorphism. Conclusion: PPAR-γ gene polymorphism is associated with and increased the risk of psoriasis and its associated obesity in Egyptian patients. It has no role in NBUVB response in those patients. Future large-scale studies on different populations are recommended.
first_indexed 2024-04-13T21:14:32Z
format Article
id doaj.art-e98a7cd87bea4e43ac3bbd594737abcf
institution Directory Open Access Journal
issn 0019-5154
1998-3611
language English
last_indexed 2024-04-13T21:14:32Z
publishDate 2019-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Dermatology
spelling doaj.art-e98a7cd87bea4e43ac3bbd594737abcf2022-12-22T02:29:44ZengWolters Kluwer Medknow PublicationsIndian Journal of Dermatology0019-51541998-36112019-01-0164319220010.4103/ijd.IJD_114_18Peroxisome proliferator-activated receptor-γ gene polymorphism in psoriasis and its relation to obesity, metabolic syndrome, and narrowband ultraviolet B response: A case–control study in Egyptian patientsIman SeleitOla Ahmed BakryEman Abd El GayedMai GhanemBackground: Psoriasis is a common dermatologic disease with multifactorial etiology in which genetic factors play a major role. Peroxisome proliferator-activated receptor (PPAR)-γ is expressed in keratinocytes and is known to affect cell maturation and differentiation in addition to its role in inflammation. Aim: To study the association between PPAR-γ gene polymorphism and psoriasis vulgaris in Egyptian patients to explore if this polymorphism influenced disease risk or clinical presentation. Methods: Forty-five patients with psoriasis vulgaris and 45 age, sex and body mass index matched healthy volunteers who have no present, past or family history of psoriasis as a control group were enrolled. Selected cases included obese and nonobese participants. Detection of PPAR-γ gene polymorphism was done with restriction fragment length polymorphism polymerase chain reaction. Narrow-band ultraviolet B (NBUVB) was given for every case three times/week for 12 weeks. Results: Homopolymorphism, heteropolymorphism, and Ala allele were significantly associated with cases (P = 0.01, P = 0.01, and P = 0.004, respectively) and increased risk of occurrence of psoriasis by 5.25, 3.65, and 3.37 folds, respectively. Heteropolymorphism was significantly associated with nonobese cases compared to obese ones (P = 0.01). Ala allele was significantly associated with obese cases (P = 0.001) and increased risk of occurrence of psoriasis in obese participants by 1.14 folds. Homopolymorphism, heteropolymorphism, and Ala allele were more prevalent among obese cases without metabolic syndrome (MS) than obese cases with MS but without statistical significance. Percentage of decrease of mean Psoriasis Area and Severity Index score before and after 3 months of treatment with NBUVB was higher in cases with heteropolymorphism with no significant difference between homo- and heteropolymorphism. Conclusion: PPAR-γ gene polymorphism is associated with and increased the risk of psoriasis and its associated obesity in Egyptian patients. It has no role in NBUVB response in those patients. Future large-scale studies on different populations are recommended.http://www.e-ijd.org/article.asp?issn=0019-5154;year=2019;volume=64;issue=3;spage=192;epage=200;aulast=SeleitGene polymorphismmetabolic syndromeobesityperoxisome proliferator-activated receptor-γpsoriasis
spellingShingle Iman Seleit
Ola Ahmed Bakry
Eman Abd El Gayed
Mai Ghanem
Peroxisome proliferator-activated receptor-γ gene polymorphism in psoriasis and its relation to obesity, metabolic syndrome, and narrowband ultraviolet B response: A case–control study in Egyptian patients
Indian Journal of Dermatology
Gene polymorphism
metabolic syndrome
obesity
peroxisome proliferator-activated receptor-γ
psoriasis
title Peroxisome proliferator-activated receptor-γ gene polymorphism in psoriasis and its relation to obesity, metabolic syndrome, and narrowband ultraviolet B response: A case–control study in Egyptian patients
title_full Peroxisome proliferator-activated receptor-γ gene polymorphism in psoriasis and its relation to obesity, metabolic syndrome, and narrowband ultraviolet B response: A case–control study in Egyptian patients
title_fullStr Peroxisome proliferator-activated receptor-γ gene polymorphism in psoriasis and its relation to obesity, metabolic syndrome, and narrowband ultraviolet B response: A case–control study in Egyptian patients
title_full_unstemmed Peroxisome proliferator-activated receptor-γ gene polymorphism in psoriasis and its relation to obesity, metabolic syndrome, and narrowband ultraviolet B response: A case–control study in Egyptian patients
title_short Peroxisome proliferator-activated receptor-γ gene polymorphism in psoriasis and its relation to obesity, metabolic syndrome, and narrowband ultraviolet B response: A case–control study in Egyptian patients
title_sort peroxisome proliferator activated receptor γ gene polymorphism in psoriasis and its relation to obesity metabolic syndrome and narrowband ultraviolet b response a case control study in egyptian patients
topic Gene polymorphism
metabolic syndrome
obesity
peroxisome proliferator-activated receptor-γ
psoriasis
url http://www.e-ijd.org/article.asp?issn=0019-5154;year=2019;volume=64;issue=3;spage=192;epage=200;aulast=Seleit
work_keys_str_mv AT imanseleit peroxisomeproliferatoractivatedreceptorggenepolymorphisminpsoriasisanditsrelationtoobesitymetabolicsyndromeandnarrowbandultravioletbresponseacasecontrolstudyinegyptianpatients
AT olaahmedbakry peroxisomeproliferatoractivatedreceptorggenepolymorphisminpsoriasisanditsrelationtoobesitymetabolicsyndromeandnarrowbandultravioletbresponseacasecontrolstudyinegyptianpatients
AT emanabdelgayed peroxisomeproliferatoractivatedreceptorggenepolymorphisminpsoriasisanditsrelationtoobesitymetabolicsyndromeandnarrowbandultravioletbresponseacasecontrolstudyinegyptianpatients
AT maighanem peroxisomeproliferatoractivatedreceptorggenepolymorphisminpsoriasisanditsrelationtoobesitymetabolicsyndromeandnarrowbandultravioletbresponseacasecontrolstudyinegyptianpatients